Abstract
Providing proper timely treatment of asthma, self-monitoring can play a vital role in disease control. Existing methods (such as peak flow meter, smart spirometer) requires special equipment and are not always used by the patient. Using voice recording as surrogate measures of lung function can be used to assess asthma, which has good potential to self-monitor asthma and could be integrated into telehealth platforms. This study aims to apply machine learning approach to predict lung functions from recorded voice for asthma patients.
A threshold-based mechanism was designed to separate speech and breathing from recordings (323 recordings from 26 participants) and features extracted from these were combined with biological attributes and lung function (percentage predicted forced expiratory volume in 1 second, FEV1%). Three predictive models were developed: (a) regression models to predict lung function, (b) multi-class classification models to predict the severity, and (c) binary classification models to predict abnormality. Random Forest (RF), Support Vector Machine (SVM), and Linear Regression (LR) algorithms were implemented to develop these predictive models. Training and test samples were separated (70%:30% using balanced portioning). Features were normalised and 10-fold cross-validation used to measure the model’s training performances on the training samples. Models were then run on the test samples to measure the final performances.
The RF based regression model performed better with lowest root mean square error = 10.86, and mean absolute score = 11.47, as compared to other models. In predicting the severity of lung function, the SVM based model performed better with 73.20% accuracy. The RF based model performed better in binary classification models for predicting abnormality of lung function (accuracy = 0.85, F1-score = 0.84, and area under the receiver operating characteristic curve = 0.88).
The proposed machine learning approach can predict lung function (in terms of FEV1%), from the recorded voice files, better than other published approaches. These models can be extended to predict both the severity and abnormality of lung function with reasonable accuracies. This technique could be used to develop future telehealth solutions including smartphone-based applications which have potential to aid decision making and self-monitoring in asthma.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The study was funded by the Asthma, Allergy and Inflammation Research Charity, Southampton, UK.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the Southampton and South West Hampshire local ethics committee, UK (LREC number 12/EE/0545) and by the Medicines and Healthcare Products Regulation Agency (MHRA), UK (MHRA number 11709/0246/001-0001).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Access to data and source code can be made available upon request.
